These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8351472)

  • 1. A study of prognosis and clinicopathology of bladder cancer to blood group type of host patients in Japan.
    Yamada T; Fukui I; Yokokawa M; Oshima H
    Scand J Urol Nephrol; 1993; 27(2):199-203. PubMed ID: 8351472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.
    Rodríguez-Alonso A; Pita-Fernández S; González-Carreró J; Nogueira-March JL
    Eur Urol; 2002 Feb; 41(2):182-8; discussion 188-9. PubMed ID: 12074407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principles of tumor invasion and metastasis].
    Otto T; Goepel M; Recker F; Rübben H
    Urologe A; 1995 May; 34(3):208-11. PubMed ID: 7610514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression predicts progression and poor survival in T1 bladder tumours.
    Llopis J; Alcaraz A; Ribal MJ; Solé M; Ventura PJ; Barranco MA; Rodriguez A; Corral JM; Carretero P
    Eur Urol; 2000 Jun; 37(6):644-53. PubMed ID: 10828662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
    Lin YL; Sun G; Liu XQ; Li WP; Ma JG
    J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M
    Scand J Urol Nephrol; 1990; 24(1):39-45. PubMed ID: 2320971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological analysis of high-grade superficial bladder tumour.
    Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Ishii N; Kawamura S; Nakada T; Suzuki K
    Int Urol Nephrol; 1991; 23(3):237-43. PubMed ID: 1889970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis.
    Collan Y; Mäkinen J; Heikkinen A
    Eur Urol; 1979; 5(5):311-8. PubMed ID: 446506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.
    Koksal IT; Yasar D; Dirice E; Usta MF; Karauzum S; Luleci G; Baykara M; Sanlioglu S
    Urol Int; 2005; 75(2):102-6. PubMed ID: 16123561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The molecular biology of bladder carcinoma].
    Moreno Sierra J; Maestro de las Casas ML; Chicharro Almarza J; Ortega Heredia MD; López García-Asenjo J; Merino Sánchez C; Blanco Jiménez E; Silmi Moyano A; Rsesel Estévez L
    Arch Esp Urol; 1997 Oct; 50(8):855-66. PubMed ID: 9463283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of nucleolar organizer regions in chromosomes of bladder cancer].
    Korneev IA
    Vopr Onkol; 2004; 50(4):449-53. PubMed ID: 15605770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy.
    Hemal AK; Khaitan A; Dinda AK; Gupta NP; Seth A; Dogra PN; Nabi G
    Urol Int; 2003; 70(1):42-6. PubMed ID: 12566814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the outcome of radical radiotherapy for invasive bladder cancer.
    Vale JA; A'Hern RP; Liu K; Hendry WF; Whitfield HN; Plowman PN; Sowter C; Slavin G
    Eur Urol; 1993; 24(1):48-51. PubMed ID: 8365439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
    Supit W; Mochtar CA; Sugiono M; Umbas R
    Asian Pac J Cancer Prev; 2011; 12(2):549-53. PubMed ID: 21545228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 20. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
    Montie JE
    J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.